Alexander Blostein

In a report published Monday, Goldman Sachs analyst Alexander Blostein upgraded the rating on CME Group (NASDAQ: CME) from Sell to Neutral, and raised the price target from $50.00 to $70.00. In the report, Goldman Sachs noted, “We upgrade shares of CME to Neutral from Sell. Despite the stock's...

Goldman Sachs analysts Marc Irizarry, Alexander Blostein and Neha Killa reiterated their Sell rating for shares of Federated Investors, Inc. (NYSE: FII). The analysts wrote that they see Federated Investors as a cyclical donor in the asset management business. They also said that Federated...